Hwail Pharmaceutical Co.,Ltd. (KOSDAQ:061250)
South Korea
· Delayed Price · Currency is KRW 1,189.00
+7.00 (0.59%)
Feb 20, 2025, 9:00 AM KST
Hwail Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | 2011 - 2007 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 19, 2025 | Dec '16 Dec 31, 2016 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 | Dec '12 Dec 31, 2012 | 2011 - 2007 |
| Market Capitalization | 96,813 | 109,671 | 87,493 | 78,703 | 80,502 | 97,411 | Upgrade
|
| Market Cap Growth | 11.11% | 25.35% | 11.17% | -2.23% | -17.36% | 168.23% | Upgrade
|
| Enterprise Value | 102,410 | 115,940 | 109,331 | 87,464 | 95,297 | 107,903 | Upgrade
|
| Last Close Price | 1190.00 | 2504.64 | 1961.20 | 1723.27 | 1696.57 | 2075.90 | Upgrade
|
| PE Ratio | 25.08 | 17.19 | 16.04 | 19.05 | 19.12 | 19.25 | Upgrade
|
| PS Ratio | 0.45 | 0.98 | 0.82 | 0.82 | 0.85 | 1.06 | Upgrade
|
| PB Ratio | 0.49 | 1.10 | 0.88 | 0.88 | 0.93 | 1.18 | Upgrade
|
| P/TBV Ratio | 1.04 | 1.15 | 0.93 | 0.93 | 0.98 | 1.19 | Upgrade
|
| P/FCF Ratio | 8.98 | 11.96 | - | - | - | - | Upgrade
|
| P/OCF Ratio | 8.69 | 11.45 | - | - | 11.55 | 96.95 | Upgrade
|
| EV/Sales Ratio | 0.95 | 1.04 | 1.03 | 0.91 | 1.01 | 1.17 | Upgrade
|
| EV/EBITDA Ratio | 19.69 | 22.33 | 23.15 | 13.38 | 13.64 | 11.96 | Upgrade
|
| EV/EBIT Ratio | 44.88 | 52.06 | 56.02 | 18.74 | 17.12 | 14.14 | Upgrade
|
| EV/FCF Ratio | 9.49 | 12.64 | - | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.16 | 0.15 | 0.27 | 0.24 | 0.25 | 0.22 | Upgrade
|
| Debt / EBITDA Ratio | 3.04 | 2.91 | 5.68 | 3.31 | 3.11 | 1.97 | Upgrade
|
| Debt / FCF Ratio | 1.47 | 1.65 | - | - | - | - | Upgrade
|
| Asset Turnover | 0.79 | 0.83 | 0.81 | 0.78 | 0.80 | 0.87 | Upgrade
|
| Inventory Turnover | 3.46 | 3.42 | 3.34 | 3.11 | 3.06 | 3.27 | Upgrade
|
| Quick Ratio | 2.55 | 2.66 | 1.46 | 2.17 | 1.66 | 1.96 | Upgrade
|
| Current Ratio | 3.68 | 3.97 | 2.42 | 3.39 | 2.86 | 3.12 | Upgrade
|
| Return on Equity (ROE) | 1.94% | 6.42% | 5.80% | 4.71% | 5.00% | 6.67% | Upgrade
|
| Return on Assets (ROA) | 1.05% | 1.04% | 0.93% | 2.37% | 2.95% | 4.50% | Upgrade
|
| Return on Capital (ROIC) | 1.19% | 1.16% | 1.03% | 2.67% | 3.35% | 5.09% | Upgrade
|
| Return on Capital Employed (ROCE) | 2.13% | 2.03% | 1.83% | 4.62% | 5.70% | 8.59% | Upgrade
|
| Earnings Yield | 1.99% | 5.82% | 6.23% | 5.25% | 5.23% | 5.19% | Upgrade
|
| FCF Yield | 11.14% | 8.36% | -9.10% | -5.33% | -2.75% | -6.90% | Upgrade
|
| Dividend Yield | 2.25% | 2.00% | - | - | - | - | Upgrade
|
| Payout Ratio | 105.38% | 31.79% | 24.80% | 32.73% | 31.20% | 20.39% | Upgrade
|
| Buyback Yield / Dilution | -0.15% | 0.06% | -0.21% | 0.24% | -1.64% | -0.03% | Upgrade
|
| Total Shareholder Return | -0.15% | 2.06% | -0.21% | 0.24% | -1.64% | -0.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.